Trending storyDeveloping

Biohaven’s previously rejected rare disease drug to get fresh FDA review

2 reports2 sourcesupdated 2 hours ago

Start here

No synthesis yet — start with the coverage timeline below.

Follow the coverage to see the different angles.

Oct 23

Oct 22

Not enough continuous observation yet to draw a trend.